SUBSCRIBE
SUBSCRIBE
News   Deals

Aspen Pharmacare Ltd. Is Behind US$585 Million Sigma Pharmaceuticals Bid; Advisors Hope to Solicitate a Superior Offer

May 24, 2010 | 
1 min read
WSJ -- Sigma Pharmaceuticals Ltd. on Monday confirmed that South Africa's Aspen Pharmacare Holdings Ltd. was behind last week's 707 million Australian dollar (US$585 million) bid for the group.
Mergers & acquisitions
MORE ON THIS TOPIC
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Mergers & acquisitions
Merck, AstraZeneca Cancer Collaborator Gets Swallowed Up by Sino Biopharm
July 16, 2025
 · 
1 min read
 · 
Tristan Manalac
Female handshake. Flat design. Two business women in green and yellow clothes against the blue background of the metropolis shake hands
Leadership
5 Women Biotech Leaders Bagging Billions in M&A Dollars
July 16, 2025
 · 
8 min read
 · 
Tristan Manalac
AbbVie's office in South San Francisco, California
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.
Gene therapy
AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M
July 9, 2025
 · 
1 min read
 · 
Dan Samorodnitsky